Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer

ABSTRACT: Colorectal cancer is an aggressive malignancy with a poor overall outcome. The purpose of this study is to evaluate the feasibility, safety and efficacy of neoadjuvant oxaliplatin, irinotecan combined with 5-fluorouraci/leucovorin or S-1 or capecitabine in patients with resectable colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2208692 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR